You Searched For "adar poonawalla" and got 20 results
Sort By:
2 mins read
Adar Poonawalla gets 50% stake in Karan Johar's Dharma Productions for ₹1,000 crore
Adar Poonawalla’s Serene Productions acquires a 50% stake in Karan Johar’s Dharma Productions and D…
2 mins read
Govt likely to float global tender for HPV vaccine in April; Merck, Serum Institute may participate
The Health Ministry intends to roll out HPV vaccine against cervical cancer in the national immunis…
PTI
1 min read
Covovax vaccine to get approval as a booster in 10-15 days: Adar Poonawalla
Asked about states and districts not getting Covishield vaccine, he said there is ample stock wi…
PTI
2 mins read
Global rollout of 12 billion Covid-19 vaccine doses largest-ever, but access is an issue: WHO
Addressing the annual general meeting of the Developing Countries Vaccine Manufacturers Network …
1 min read
Cyrus Poonawalla’s wealth grows as his health empire remains unlisted
All top 10 billionaires of India in Hurun Rich List saw decline in money except Cyrus Poonwalla
Bhakti Makwana
2 mins read
TPG to acquire Adar Poonawalla-led group’s housing finance arm at ₹3,900 crore valuation
US-based private equity major TPG has agreed to acquire the housing finance arm of Adar Poonawalla-…
2 mins read
More than 3.3 million people lost life to COVID-19 in 2021 — more than HIV, malaria and tuberculosis related deaths combined in 2020
The World Health Organisation (WHO), on Tuesday, revealed that more than 3.3 million people lost th…
1 min read
Serum Institute to roll out COVID-19 vaccine for children in six months, says CEO Adar Poonawalla
"We haven't seen a lot of severe disease in children. Fortunately, the panic is not there fo…
PTI
3 mins read
US-based biotechnology company Novavax’s COVID-19 shot is 90% effective
US-based biotechnology company Novavax's protein-based vaccine has shown overall 90 per cent effica…
1 min read
Adani Transmission, Sun Pharma, Vedanta among stocks to watch out for on June 6
Indian markets may start the week on a negative note as SGX Nifty, an early indicator of the market…
Bhakti Makwana
1 min read
Adar Poonawalla-backed pharmacy chain Wellness Forever files for IPO
Apart from a fresh issue worth up to ₹400 crore, there will be an Offer for Sale (OFS) wherein…
PTI
3 mins read
Adar Poonawalla's Serum cuts Covishield vaccine price for state governments to ₹300 a dose after much backlash
In a tweet, Poonawalla called this cut a "philanthropic gesture" that will save crores of rupees…
3 mins read
If 2015 was the ‘Year of the API’, why is there a Remdesivir shortage six years later?
Catchphrases don’t cure, actual drugs do. In fact, since 2015, the year when the government…
1 min read
Serum Institute's second COVID-19 vaccine 'Covavax' likely to be launched in September
Serum Institute of India, the world's biggest Covid-19 vaccine maker, is hopeful to launch Covovax …
2 mins read
SII CEO believes 'vaccine nationalism' in India and the US could derail efforts to deliver two billion doses to poorer nations
Adar Poonawalla, CEO, Serum Institute of India (SII) has said that vaccine nationalism in countries…
2 mins read
India’s vaccine king Adar Poonawalla will pay $69,000 a week to live on the same neighbourhood as Winston Churchill once did
Poonawalla, who is an alumnus of the University of Westminster, has often referred to London…
4 mins read
COVID-19 vaccine will be priced at ₹1,000 and would be available by February for healthcare workers and elderly people, says Serum CEO Adar Poonawalla
"It will probably take two or three years for every Indian to get inoculated, not just because o…
PTI
2 mins read
Here's an indicative timeline for the Oxford vaccine — from phase-3 trials to the final supply in the market
SII, the world’s largest vaccine manufacturer, earlier in April, partnered with the University o…
2 mins read
Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 billion
In addition to vaccines, the strategic alliance will also develop antibodies targeting seve…
PTI
2 mins read
The Oxford COVID-19 vaccine will only cost the Indian government $3 per dose, reveals Adar Poonawalla
The CEO of Serum Institute of India (SII), the company conducting the clinical trials of the vac…